Research site

Alergo Med Osrodek Badan Klinicznych Sp. z o.o.

Poland Ul. Polskiego Czerwonego Krzyza 26, 33-100 Tarnow, Poland

9 trials recruiting
Dermatitis atopic · Asthma · Chronic spontaneous urticaria
Adults and children

About Specializations

Alergo Med Osrodek Badan Klinicznych Sp. z o.o. in Tarnow, Poland specialises in clinical trials of conditions such as Dermatitis atopic, Asthma, Chronic spontaneous urticaria, Cough, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Medicine

The medical center is at the forefront of Respiratory Medicine, focusing on innovative treatments for chronic respiratory conditions. The center's research is pivotal in enhancing the understanding and management of complex respiratory diseases.

Chronic Obstructive Pulmonary Disease (COPD)
Chronic Bronchitis

By conducting cutting-edge clinical trials, the center contributes significantly to the development of new therapeutic strategies, improving patient outcomes and quality of life for those suffering from chronic respiratory ailments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Ul. Polskiego Czerwonego Krzyza 2633-100 TarnowPoland

Open in maps ↗

Recruiting now: 9 trials
Conditions studied: 13

More sites in Tarnow Poland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

30 clinical trials

Asthma

Recruiting

Registered drug

Efficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma

Registered drug

Poland

Participants:0–17 years
Substances:Indacaterol Acetate
Sponsor:Novartis Pharma AG

Contact Research Centre

Cold urticaria

Recruiting

Registered drug

A study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Barzolvolimab
Sponsor:Celldex Therapeutics Inc.

Contact Research Centre

Chronic spontaneous urticaria

Recruiting

Registered drugNo placebo

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Barzolvolimab
Sponsor:Celldex Therapeutics Inc.

Contact Research Centre

Conjunctivitis allergic

Recruiting

Registered drug

Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen

Registered drug

Poland

Participants:0–17 years
Substances:Desloratadine
Sponsor:Allergy Therapeutics (UK) Limited

Contact Research Centre

Dermatitis atopic

Recruiting

InvestigationalNo placebo

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Infants 6–23 Months with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo

Poland

Participants:0–17 years
Substances:Nemolizumab
Sponsor:Galderma S.A.

Contact Research Centre

Asthma

Recruiting

Investigational

Efficacy and Safety of Inhaled Glycopyrronium Bromide Added to Budesonide and Formoterol Fumarate in Children 4‑12 Years with Asthma (Placebo‑Controlled)

Investigational

Poland

Participants:0–17 years
Substances:Budesonide
Sponsor:AstraZeneca AB

Contact Research Centre

Chronic spontaneous urticaria

Recruiting

Investigational

A study to evaluate the efficacy and safety of lesigercept in adults with chronic spontaneous urticaria who do not have enough relief from antihistamines

Investigational

Poland

Participants:18–64 years · 65+ years
Sponsor:Yuhan Corp.

Contact Research Centre

Asthma

Recruiting

Registered drugNo placebo

Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Placebo
Sponsor:Chiesi Farmaceutici S.p.A.

Contact Research Centre

Respiratory syncytial virus infection

Recruiting

Investigational

A Study of S-337395 for Adults Not in Hospital with Respiratory Syncytial Virus Who Are at High Risk of Severe Disease

Investigational

Poland

Participants:18–64 years · 65+ years
Sponsor:Shionogi B.V.

Contact Research Centre

Dermatitis atopic

Not yet recruiting

Investigational

Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Img-007
Sponsor:Inmagene LLC

Contact Research Centre

Acne

Not yet recruiting

Investigational

Safety and Efficacy Study of the Acne mRNA vaccine (mrt1800, mrt1801, mrt1802) in Adults 18‑45 Years with Moderate to Severe Acne

Investigational

Poland

Participants:18–64 years
Sponsor:Sanofi Pasteur Inc.

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis

Investigational

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Rocatinlimab
Sponsor:Amgen Inc.

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites